Acasă › Cancer de sân triplu negativ › Illinois › Chicago
Studii clinice pentru Cancer de sân triplu negativ în Chicago, IL
16 studii pentru Cancer de sân triplu negativ caută participanți în și în jurul orașului Chicago (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
În curs de recrutareFaza 1
- University of Chicago Hospital, Chicago
PRE-ISPY Phase I/II Oncology Platform Program
În curs de recrutareFaza 1/2
- The University of Chicago Medicine Comprehensive Cancer Center, Chicago
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
În curs de recrutareFaza 3
- University of Illinois Cancer Center ( Site 0044), Chicago
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
În curs de recrutareFaza 1
- Northwestern University Feinberg School of Medicine, Chicago
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
În curs de recrutareFaza 3
- Northwestern Medicine, Chicago
- Rush University Medical Center, Chicago
- University of Chicago Medical Center, Chicago
SMP-3124LP in Adults With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Northwestern Medicine Cancer Center, Chicago
- The University of Chicago, Chicago
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
În curs de recrutareFaza 2/3
- Local Institution - 0280, Chicago
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
În curs de recrutareFaza 1/2
- Northwestern University, Chicago
A Study of LY4175408 in Participants With Advanced Cancer
În curs de recrutareFaza 1
- The University of Chicago Medical Center (UCMC), Chicago
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
În curs de recrutareFaza 1
- University of Illinois Hospital and Health Sciences System /ID# 251750, Chicago
- University of Chicago Medical Center /ID# 276271, Chicago
Study of XB010 in Subjects With Solid Tumors
În curs de recrutareFaza 1
- University of Chicago Medical Center, Chicago
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
În curs de recrutareFaza 1/2
- Northwestern Memorial Hospital, Chicago
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
În curs de recrutareFaza 2
- University of Chicago, Chicago
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
În curs de recrutareFaza 2
- University of Chicago Medical Center, Chicago
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs
În curs de recrutareFaza 1
- UChicago Medicine Comprehensive Cancer Center, Chicago
A Study of NX-1607 in Adults With Advanced Malignancies
În curs de recrutareFaza 1
- University of Chicago, Chicago
Studii pentru Cancer de sân triplu negativ în alte orașe
- Houston, TX42 studii
- New York City, NY31 studii
- Nashville, TN28 studii
- Los Angeles, CA27 studii
- Boston, MA26 studii
- San Antonio, TX23 studii
- St. Louis, MO21 studii
- Arlington, VA20 studii
- Atlanta, GA20 studii
- Dallas, TX18 studii
- Columbus, OH16 studii
- Grand Rapids, MI15 studii
Alte studii în Chicago
- Cancer pulmonar cu celule non-pătrate61 studii
- Cancer de sân59 studii
- Cancer (toate tipurile)51 studii
- Cancer metastatic45 studii
- Cancer de prostată45 studii
- Cancer pulmonar41 studii
- Obezitate41 studii
- Cancer ovarian36 studii
- Cancer colorectal34 studii
- Accident vascular cerebral34 studii
- Insuficiență cardiacă31 studii
- Supraponderalitate29 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.